logo
Quantification of HIV-specific CD8 T cells by in vitro stimulation with inactivated viral particles
Limited immune restoration after 3 years’ suppression of HIV-1 replication in patients with moderately advanced disease
Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients
Discordant response to antiretroviral therapy
Temporal relationship between V1V2 variation, macrophage replication, and coreceptor adaptation during HIV-1 disease progression
HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades
HIV dementia patients exhibit reduced viral neutralization and increased envelope sequence diversity in blood and brain
Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects
Pathological findings in the central nervous system of AIDS patients on assumed antiretroviral therapeutic regimens
No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy
Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality
Late diagnosis of HIV infection in the era of highly active antiretroviral therapy
Are HIV care providers talking with patients about safer sex and disclosure?
Evolution of the gp41 env region in HIV-infected patients receiving T-20, a fusion inhibitor
Biphasic decay of cell-associated HIV-1 DNA in HIV-1-infected children on antiretroviral therapy
Impact of HIV genotyping and drug levels on the response to salvage therapy with saquinavir/ritonavir
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy
A prospective case–control survey of laboratory markers of skeletal muscle damage during HIV disease and antiretroviral therapy
Vascular disease in HIV-infected patients
Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease
High incidence of tuberculin skin test conversion among HIV-infected individuals who have a favourable immunological response to highly active antiretroviral therapy
Plasmablastic lymphoma of the oral cavity and jaws
Abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-positive patients
Efficacy and safety of fluvastatin in hyperlipidemic protease inhibitor-treated HIV-infected patients
Lipid changes in HIV-infected patients who started rescue therapy with an amprenavir/ritonavir-based highly active antiretroviral therapy
Correction of facial lipoatrophy in HIV-infected patients on highly active antiretroviral therapy by injection of autologous fatty tissue
ERRATUM